Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

被引:50
|
作者
Choi, Hyun Sook [1 ,2 ]
Park, Mi Sook [1 ,2 ]
Kim, Seung Hwan [3 ]
Hwang, Bang Yeon [1 ,2 ]
Lee, Chong Kil [1 ,2 ]
Lee, Myung Koo [1 ,2 ]
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[2] Chungbuk Natl Univ, Res Ctr Bioresource & Hlth, Cheongju 361763, South Korea
[3] Kyung Hee Univ, Coll Phys Educ, Yongin 449701, South Korea
来源
MOLECULES | 2010年 / 15卷 / 04期
关键词
Gynostemma pentaphyllum; 6-hydroxydopamine-lesioned rats; tyrosine hydroxylase; dopamine; Parkinson's disease; L-DOPA; CUCURBITACEAE PLANTS; SAPONIN CONSTITUENTS; BRAIN; 6-OHDA; CELLS; IRON;
D O I
10.3390/molecules15042814
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
6-Hydroxydopamine administration for 28 days (8 mu g/2 mu L) reduced the number of tyrosine hydroxylase (TH)-immunopositive neurons to 40.2% in the substantia nigra compared to the intact contralateral side. Dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine levels were reduced to 19.1%, 52.3%, 47.1% and 67.4% in the striatum of 6-hydroxydopamine-lesioned rats compared to the control group, respectively. However, an oral administration of herbal ethanol extracts from Gynostemma pentaphyllum (GP-EX) (10 mg/kg and 30 mg/kg) starting on day 3 post-lesion for 28 days markedly ameliorated the reduction of TH-immunopositive neurons induced by 6-hydroxydopamine-lesioned rat brain from 40.2% to 67.4% and 75.8% in the substantia nigra. GP-EX administration (10 and 30 mg/kg) also recovered the levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine in post-lesion striatum to 64.1% and 65.0%, 77.9% and 89.7%, 82.6% and 90.2%, and 88.1% and 89.2% of the control group. GP-EX at the given doses did not produce any sign of toxicity such as weight loss, diarrhea and vomiting in rats during the 28 day treatment period and four gypenoside derivatives, gynosaponin TN-1, gynosaponin TN-2, gypenoside XLV and gypenoside LXXIV were identified from GP-EX. These results suggest that GP-EX might be helpful in the prevention of Parkinson's disease.
引用
收藏
页码:2814 / 2824
页数:11
相关论文
共 50 条
  • [41] Anxiolytic Effects of Herbal Ethanol Extract from Gynostemma pentaphyllum in Mice after Exposure to Chronic Stress
    Choi, Hyun Sook
    Zhao, Ting Ting
    Shin, Keon Sung
    Kim, Seung Hwan
    Hwang, Bang Yeon
    Lee, Chong Kil
    Lee, Myung Koo
    MOLECULES, 2013, 18 (04) : 4342 - 4356
  • [42] NEUROPROTECTIVE EFFECTS OF SWIMMING TRAINING IN A MOUSE MODEL OF PARKINSON'S DISEASE INDUCED BY 6-HYDROXYDOPAMINE
    Goes, A. T. R.
    Souza, L. C.
    Filho, C. B.
    Del Fabbro, L.
    De Gomes, M. G.
    Boeira, S. P.
    Jesse, C. R.
    NEUROSCIENCE, 2014, 256 : 61 - 71
  • [43] The role of valproic acid and levodopa on oxidative stress in a 6-hydroxydopamine lesioned rat model of Parkinson's disease
    Dagdelen, M.
    Akkaya, H.
    Genc, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S197 - S197
  • [44] Fibroblast growth factor-20 protects against dopamine neuron loss in vitro and provides functional protection in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Sleeman, Isobel J.
    Boshoff, Eugene L.
    Duty, Susan
    NEUROPHARMACOLOGY, 2012, 63 (07) : 1268 - 1277
  • [45] THE ROTATING 6-HYDROXYDOPAMINE-LESIONED MOUSE AS A MODEL FOR ASSESSING FUNCTIONAL-EFFECTS OF NEURONAL GRAFTING
    BRUNDIN, P
    ISACSON, O
    GAGE, FH
    PROCHIANTZ, A
    BJORKLUND, A
    BRAIN RESEARCH, 1986, 366 (1-2) : 346 - 349
  • [46] Investigation of Neuroprotective Effects of Cyclooxygenase Inhibitors in the 6-Hydroxydopamine Induced Rat Parkinson Model
    Goren, Buelent
    Mimbay, Zehra
    Bilici, Nebahat
    Zarifoglu, Mehmet
    Ogul, Erhan
    Korfali, Ender
    TURKISH NEUROSURGERY, 2009, 19 (03) : 230 - 236
  • [47] Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease
    Crotty, S.
    Fitzgerald, P.
    Tuohy, E.
    Harris, D. M.
    Fisher, A.
    Mandel, A.
    Bolton, A. E.
    Sullivan, A. M.
    Nolan, Y.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (02) : 294 - 300
  • [48] Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease
    Quintero, Elias Matthew
    Willis, Lauren
    Singleton, Rachel
    Harris, Naida
    Huang, Peng
    Bhat, Narayan
    Granholm, Ann-Charlotte
    BRAIN RESEARCH, 2006, 1093 : 198 - 207
  • [49] Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease
    Vernon, AC
    Palmer, S
    Datla, KP
    Zbarsky, V
    Croucher, MJ
    Dexter, DT
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (07) : 1799 - 1806
  • [50] Neuroprotective Effect of Pseudoginsenoside-F11 on a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
    Wang, Jian Yu
    Yang, Jing Yu
    Wang, Fang
    Fu, Shi Yuan
    Hou, Yue
    Jiang, Bo
    Ma, Jie
    Song, Cui
    Wu, Chun Fu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013